Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis.
D000549:Ambenonium Chloride / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000032:analysis*; D002648:Child; D004247:DNA / Q000276:immunology*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000628:therapy*; D009187:Myelitis / Q000150:complications*; D009188:Myelitis, Transverse / Q000150:complications*; D009902:Optic Neuritis / Q000150:complications*; D013601:T-Lymphocytes / Q000145:classification; D013934:Thymectomy
D000974:Antibodies, Antinuclear; D000549:Ambenonium Chloride; D004247:DNA